Current Edition

Alofisel

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

  First allogeneic stem cell therapy to receive central marketing authorization approval in Europe Alofisel offers a new treatment option for patients who do not …

Continue Reading →